Stock screener

RXST

Conviction 59HealthcareScan · Mon, Aug 10, 2026
RXST$6.55+4.63%
ResistanceSupportVol 14
63 bars
Vol MA14 1.04M
May 11May 28Jun 16Jul 6Jul 23Aug 10
RxSight, Inc.OPHTHALMIC GOODSwww.rxsight.com
Price6.55
Change+4.63%
Gap-0.48%
Rel volume3.17×
Avg volume1.08M
Avg $ vol6.3M
SMA 205.79
SMA 505.34
SMA 2007.79
Price vs 50+22.56%
Price vs 200-15.86%
MA stackmixed
50/200 cross
Supertrendup · 5.21
RSI (14)66
MACD hist0.07
MACD cross
Stoch %K / %D98 / 87
ADX (14)16
+DI / −DI28 / 22
RSI divergence
MACD divergence
ATR %+6.06%
ADR %6.64%
52w high13.09
52w low4.59
From 52w high-49.96%
Above 52w low+42.70%
New 52w highNo
SqueezeOff
Bollinger width31.33%
%B0.92
Donchian pos98.00%
Donchian high6.59
Donchian low4.84
AVWAP (52w high)7.08
vs AVWAP high-7.52%
AVWAP (52w low)5.39
vs AVWAP low+21.46%
OBV trendUp
Chaikin MF (20)0.41
Today vs 20d3.17×
Avg vol (14d)1.04M
Avg vol (20d)1.08M
Avg $ vol (20d)6.3M
Market cap272.44M
RS 3m (vs SPY)+2.23%
RS 6m (vs SPY)-34.06%
RS line new highNo
Trend template3/8
Technical rank46.2
1 week+4.13%
1 month+32.32%
3 months+11.97%
6 months-21.93%
1 year-15.92%
YTD-36.90%
P/E-7.00
P/B1.03
P/S2.03
P/FCF-14.09
EPS-0.9500
Div yield
ROE-14.79%
ROA-11.04%
Debt/Eq0.00
Current4.07
EV/EBITDA-5.77
Gross margin76.60%
Net margin-28.96%
Rev growth-3.89%
EPS growth-41.85%
Price target7.79
Target upside18.93%
Analyst ratingHold
Institutional103.20%
Ent. value259.08M
Revenue27.24M
Net income-12.1M
Gross profit23.5M
Free cash flow-19.34M
IndustryOPHTHALMIC GOODS
ExchangeNasdaq
Shares out41.4M
Employees461
ListedFri, Jul 30, 2021
Free float37.79M
Float %91.9%
Short interest3.84M
Days to cover2.8d
Short volume47.1%
Squeeze score54 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.29 vs −$0.37
Last surprise+21.6% beat
Setup gradeC
Conviction59 / 100
Pattern quality
Tech rank46.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance6.33
Support4.64
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RXST

All disclosures →
No recent disclosed trades by Congress in RXST. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RXST · 10 buys

InsiderSideShares
Fountain Tamara
Director · Common Stock · 2026-06-17
Grant37.04K
LINK WILLIAM J PHD
Director · Common Stock · 2026-06-17
Grant37.04K
Corley Jesse Anderson
Director · Common Stock · 2026-06-17
Grant37.04K
Maniar Shweta
Director · Common Stock · 2026-06-17
Grant37.04K
PALMISANO ROBERT J
Director · Common Stock · 2026-06-17
Grant37.04K
Tammenoms Bakker Juliet
Director · Common Stock · 2026-06-17
Grant37.04K
Warner Robert Keith
Director · Common Stock · 2026-06-17
Grant37.04K
COHEN RAYMOND W
Director · Common Stock · 2026-06-17
Grant30.86K
Andrews Julie
Director · Common Stock · 2026-06-17
Grant37.04K
Goldshleger Ilya
Chief Operating Officer · Common Stock · 2026-04-17
Exercise12.49K

SEC filings

EDGAR filings in RXST · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.